{
  "6283947_syn_1": "Indication: Mediastinal Adenopathy.\nProcedure: EBUS-TBNA.\nNodes Sampled:\n- 7 (Subcarinal): ROSE Positive.\n- 4R/4L: Sampled.\n- 10L/11L: Sampled.\nTotal 5 stations. 14 passes.\nDx: N3 Disease (Stage IIIB).\nPlan: Onc consult.",
  "6283947_syn_2": "PROCEDURE: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA).\nPATIENT: [REDACTED].\nCLINICAL SUMMARY: Evaluation of mediastinal lymphadenopathy in the setting of a LUL mass. A systematic EBUS survey was conducted. Lymph node stations 4R, 4L, 7, 10L, and 11L were visualized and sampled. Rapid On-Site Evaluation (ROSE) confirmed squamous cell carcinoma in the subcarinal (7) and contralateral (4R) stations, confirming N3 disease. The procedure was uncomplicated.",
  "6283947_syn_3": "CPT 31653 Justification:\n- Modality: EBUS-TBNA.\n- Scope: Linear array EBUS.\n- Work: Sampling of 3 or more mediastinal/hilar nodes.\n- Stations: 4R, 4L, 7, 10L, 11L (5 distinct stations).\n- Outcome: Diagnosis of malignancy established.",
  "6283947_syn_4": "Procedure: EBUS\nPatient: [REDACTED]\nSteps:\n1. Scope in. Airway exam normal.\n2. Ultrasound survey: 4R, 4L, 7 big.\n3. Needles into 7, 4R, 4L, 10L, 11L.\n4. Pathologist in room said its cancer (Squamous).\n5. No bleeding.\nPlan: Oncology referral.",
  "6283947_syn_5": "note for Steven Roberts doing ebus for staging. he has lul mass. we poked a bunch of nodes station 7 4r 4l 10l 11l. rose said squamous cell ca. looks like stage 3b at least since both sides positive. no issues during case minimal blood. woke up fine.",
  "6283947_syn_6": "EBUS-TBNA. Patient: Edward Carter. Stations Sampled: 4R (21mm), 4L (27mm), 7 (33mm), 10L (15mm), 11L (18mm). Needle: 22G. Passes: 14 total. ROSE Results: Squamous cell carcinoma confirmed in Station 7 and 4L. Diagnosis: N3 Malignancy. Complications: None.",
  "6283947_syn_7": "[Indication] LUL mass, mediastinal adenopathy.\n[Anesthesia] Moderate Sedation.\n[Description] EBUS-TBNA of stations 4R, 4L, 7, 10L, 11L. ROSE confirmed Squamous Cell Carcinoma.\n[Plan] Oncology referral for Stage IIIB disease.",
  "6283947_syn_8": "[REDACTED] an EBUS procedure to check the lymph nodes in the center of his chest. We found enlarged nodes on both the left and right sides. We used a special needle to take samples from five different areas. Unfortunately, the preliminary results show that the cancer has spread to these nodes, which is an important finding for determining the best treatment. We will have the final report in a few days.",
  "6283947_syn_9": "Operation: Endobronchial ultrasound with transbronchial needle aspiration.\nSubject: [REDACTED].\nFindings: Enlarged lymph nodes id[REDACTED] at stations 7, 4R, and 4L. These were aspirated along with 10L and 11L. Cytology confirmed malignancy (Squamous cell). This establishes N3 nodal involvement.",
  "6283947": "Patient: [REDACTED] | ID#: 6283947 | Date: [REDACTED]\nAttending: Dr. Harris, Stephanie\nProcedure: EBUS-TBNA for suspicious nodes\nIndication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes\nConsent: Yes, documented\nMeds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg)\nSurvey results:\n•\t2R: 8mm (normal)\n•\t2L: not seen\n•\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features\n•\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma\n•\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed\n•\t10L: 15mm (sampled) - ROSE: Positive for malignancy\n•\t11L: 18mm (sampled) - ROSE: Reactive\nTotal passes: 14 Stations sampled: 5\nComplications: None Blood loss: Minimal\nDiagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum\nNext: Oncology, radiation oncology consult, tumor board\nS. Harris MD | [REDACTED] 1445\n________________________________________\n\nMETROPOLITAN HOSPITAL DEPARTMENT OF PULMONARY MEDICINE PROCEDURE DOCUMENTATION\n│PATIENT│ Scott, Jennifer R │ MRN │ 4857392 │ DOB │ [REDACTED]\n│ DATE │ [REDACTED]\n│PROCEDURE│ EBUS-TBNA │PROVIDER │ Yang, Peter MD, PhD │FELLOW │ Morrison, Ashley MD\n═══ CLINICAL SCENARIO ═══\n54F never-smoker with cryptogenic organizing pneumonia (COP) on CT, hilar/mediastinal lymphadenopathy. R/O sarcoid vs ILD vs atypical infection vs occult malignancy.\nPET shows moderate FDG uptake nodes at 4R, 7, 10R (SUV 3-4 range)\nLabs: Normal CBC, CMP. ACE level elevated at 82 (normal <40)\n═══ INFORMED CONSENT ═══ Risks discussed: bleeding, infection, pneumothorax, failure to diagnose, need additional procedures. Patient agreed, signed consent form.\n═══ ANESTHESIA PROTOCOL ═══ Moderate conscious sedation\n•\tMidazolam 2mg IV at T=0\n•\tFentanyl 50mcg IV at T=2min\n•\tPropofol 20mg IV boluses PRN (total 80mg)\nTopical:\n•\tHurricane spray (benzocaine 20%) to posterior pharynx\n•\tLidocaine 2% via bronchoscope: 16mL instilled incrementally\nVitals stable throughout, SpO2 92-96% on 4L NC\n═══ EQUIPMENT ═══ Pentax EB-1970UK Linear EBUS Bronchoscope Ultrasound: Hi Vision Preirus Needles: 22G Olympus\n═══ FINDINGS ═══\nAIRWAY EXAM: Normal vocal cord function Trachea patent, no stenosis Main carina sharp Bilateral airways patent Mild inflammatory changes bilateral lower lobes\nULTRASOUND LYMPH NODE SURVEY:\nStation 2R: 10mm, normal architecture Station 4R: 22mm x 13mm └─ Heterogeneous echotexture\n└─ Oval shape, maintained borders\nStation 4L: 18mm x 11mm └─ Similar appearance to 4R\nStation 7: 29mm x 19mm └─ Enlarged └─ Hypoechoic └─ Loss of normal hilum\nStation 10R: 19mm x 12mm └─ Round morphology └─ Abnormal echo pattern\nStation 11R: 16mm x 10mm └─ Mildly enlarged\nTRANSBRONCHIAL NEEDLE ASPIRATION:\n► STATION 7 [29mm] Pass 1 (1022): Good aspirate obtained → ROSE: ADEQUATE. Non-necrotizing granulomas with giant cells. Pass 2 (1024): Confirmatory → ROSE: Consistent granulomatous inflammation. NO MALIGNANCY. Pass 3 (1026): Microbiology specimen → Sent for AFB, fungal, bacterial cultures Pass 4 (1028): Flow cytometry (r/o lymphoma) → Preliminary: Polyclonal lymphoid population\n► STATION 4R [22mm]\nPass 1-2 (1031-1033): → ROSE: Granulomas present, similar to Station 7\n► STATION 10R [19mm] Pass 1-2 (1036-1038): → ROSE: Granulomatous inflammation\n► STATION 11R [16mm] Pass 1 (1040): → ROSE: Reactive lymphoid hyperplasia with granulomas\nHemostasis confirmed after each sampling. No significant bleeding noted.\n═══ RAPID ON-SITE EVALUATION ═══ Cytopathologist: Dr. Rachel Cohen\nAll sampled stations show NON-NECROTIZING GRANULOMAS with multinucleated giant cells. No caseation. No malignancy. No organisms on preliminary AFB stain.\nINTERPRETATION: Findings most consistent with SARCOIDOSIS\n═══ SPECIMENS ═══ □ Cytology: Stations 7, 4R, 10R, 11R (4 vials) □ Cell blocks: Station 7 (1 vial) □ Flow cytometry: Station 7 (1 tube) □ Microbiology: Station 7 • AFB culture (1 vial) • Fungal culture (1 vial) • Bacterial culture (1 vial)\n═══ PROCEDURAL DATA ═══ Start time: 1015 End time: 1048 Duration: 33 minutes Needle passes: 9 total Fluoroscopy: Not used EBL: <5mL\n═══ COMPLICATIONS ═══ None\n═══ POST-PROCEDURE ═══ Patient tolerated well Recovered from sedation appropriately\nVital signs stable No respiratory distress Discharged to home after 90-minute observation\n═══ ASSESSMENT ═══\n2.\tSuccessful EBUS-TBNA with adequate tissue sampling\n3.\tROSE cytology consistent with SARCOIDOSIS (Stage II - bilateral hilar and mediastinal lymphadenopathy)\n4.\tNo evidence of malignancy\n5.\tFinal pathology and cultures pending\n═══ PLAN ═══\n▶ FOLLOW-UP:\n•\tPulmonology clinic 2 weeks\n•\tReview final pathology and culture results\n•\tIf cultures negative: Confirm diagnosis sarcoidosis\n▶ ADDITIONAL TESTING:\n•\tPFTs with DLCO (if not recent)\n•\tOphthalmology evaluation (baseline exam)\n•\t24-hour urine calcium\n•\tVitamin D level\n▶ TREATMENT CONSIDERATION:\n•\tIf symptomatic → Consider systemic corticosteroids\n•\tIf asymptomatic → Observe, serial imaging\n•\tCOP vs sarcoid discussion: Imaging and clinical context favor sarcoid, biopsy confirms\n▶ PATIENT EDUCATION:\n•\tSarcoidosis diagnosis explained\n•\tPrognosis discussed (generally favorable)\n•\tWritten materials provided\n•\tSupport group information given\n═══ SIGNATURE ═══\nPeter Yang, MD, PhD, FCCP Interventional Pulmonology\nElectronically signed: [REDACTED] 11:30\n═══════════════════════════════════════\n________________________________________"
}
